Allostasis is the physiologic process by which the body changes set points to meet acute demand — heart rate rises during a sprint, blood pressure climbs during a difficult conversation, insulin secretion surges after a meal — and then returns to baseline once the stressor passes. The concept was formalized by McEwen and Stellar in 1993 to describe a body that adapts on the fly rather than defends a single fixed homeostatic point. Allostatic load is the cumulative wear and tear that accrues when the system is asked to mount these adaptive responses too often, too long, or without adequate recovery. The chronic load is not abstract; it shows up as persistently elevated cortisol, sympathetic dominance, low-grade inflammation, reduced heart-rate variability, hypertension, and progressive endothelial damage.
Juster, McEwen, and Lupien synthesized the biomarker literature and described a canonical allostatic-load index that aggregates measures across neuroendocrine, immune, metabolic, and cardiovascular systems. As the index rises, cognitive performance falls and cardiovascular event rates climb in dose-dependent fashion across diverse cohorts. Subsequent epidemiologic work has confirmed the prognostic value at the population level. Bruun-Rasmussen and colleagues, in a Danish population cohort of more than thirteen thousand adults, combined ten biomarkers across cardiovascular, inflammatory, and metabolic systems into a composite allostatic-load index and showed that the highest-load category carried more than twice the all-cause mortality risk of the lowest over an average follow-up of roughly two and a half years. The body that never gets to rest is biologically aging at an accelerated rate, regardless of how the resulting blood pressure number is treated.
The clinical implication reframes hypertension and metabolic syndrome as downstream signs of an upstream load. Antihypertensives lower a number; they do not lower the underlying allostatic burden. True remission of chronic-stress physiology requires deliberate reduction of the stressors themselves — boundaries around work hours, restoration of sleep architecture, regular vagal-recovery practices, financial and relational stabilization, and the unfashionable but essential acknowledgement that the patient cannot keep operating in crisis mode indefinitely. Pharmacotherapy remains appropriate for the measured cardiovascular risk it addresses, but the more durable wins come from interventions that reduce the demand the system is being asked to meet. Cardiovascular medicine has long known how to treat blood pressure; it is now learning to ask what is making the pressure rise in the first place.
References:
- McEwen, B. S., & Stellar, E. (1993). Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine, 153(18), 2093-2101.
- Juster, R. P., McEwen, B. S., & Lupien, S. J. (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience and Biobehavioral Reviews, 35(1), 2-16.
- Bruun-Rasmussen, N. E., Napolitano, G., Christiansen, C., Bojesen, S. E., Ellervik, C., Jepsen, R., et al. (2022). Allostatic load as predictor of mortality: A cohort study from Lolland-Falster, Denmark. BMJ Open, 12(5), e057136.
Comments are closed